Dean Erhardt, Dan Steiber and David Suchanek establish D2 to offer turn-key commercialization services to biopharmaceutical companies.
Added Managed Markets consulting to the services portfolio.
Expanded financial analytics. Added reimbursement expertise. Introduced GPO consulting and sales support.
D2 continues to expand services in the pharmacy operations area with URAC, ACHC, VIPPs and other certification expertise.
D2 continues to add expertise and service tools that drive effective decision making and operational efficiencies to our customers.
New support services added for specialty pharmacies including sales planning and consulting, compliance and reaccreditation support services.
Value-based contracting advisement and planning services for manufacturers’ managed care teams.
D2’s culture can be described as collaborative, strategic and results oriented.
We believe that our combination of strategy development and tactical execution makes D2 unique in the industry.
Our team is comprised of experienced industry personnel from across a multitude of disciplines within the pharmaceutical, biotech and medical device arenas, including: Third Party Logistics (3PL), Wholesale, Retail, PBM, LTC, Hospital/IDN, Specialty/Infusion Pharmacy, Specialty Distribution, Mail Order, Manufacturer, and Payer including: Commercial, Government, GPO and Employer Groups. We hold ourselves to the highest standards of accountability and are committed to your success.
We’ve launched hundreds of products over the years and can provide both the buyer (SP, PBM, Wholesaler, Retailer etc.) and the Seller (manufacturer) perspective.
Further, we believe that our one of a kind industry reach in working across the distribution and reimbursement channels provides a unique perspective to our customers in understanding the financial and operational impact of key decisions.
Mr. Suchanek brings over 25 years of experience focused on patient services and specialty pharmacy operations. Prior to joining D2, Mr. Suchanek served as Vice President of Pharma Programs at CuraScript (specialty division of Express Scripts, Inc.) where he had responsibility for some of the organizations largest and most profitable business product/disease segments.
Mr. Brannan offers nearly two decades of healthcare distribution, operations, and sales experience. He began his career as an Account Manager at McKesson and was quickly promoted to VP of Sales for McKesson Plasma and Biologics in charge of new customer acquisition initiatives, GPO contracting opportunities, contract negotiations and new business launches. As the VP of Operations at McKesson Plasma and Biologics, Mr. Brannan was responsible for large institutions, manufacturers, group purchasing organizations, and sales force management, focusing on knowledge transfer, contract negotiations, pricing analysis, complex launches and best practices.
Ms. Gittinger joined the D2 team as a part time consultant assisting with reimbursement projects in the Medicare and Medicaid arenas. She officially joined D2 as a full-time member in 2014 and brings 20+ years of experience within the Healthcare and Insurance industries. She has in-depth knowledge of the criteria and processes necessary to achieve positive reimbursement outcomes for drugs, medical devices and biotech therapies amongst public and private payer organizations, with specific emphasis in Medicare, Medicaid, and managed Medicaid programs. Ms. Gittinger currently leads payer strategy development and coverage and policy implementation related to the public and government payer markets.
Ms. Naz joined D2 in 2017 to assist with payer strategies, contracting and various growth opportunities. Ms. Naz has in-depth knowledge of FDA regulatory strategies, payer data criteria, and payer contract strategies necessary to achieve positive reimbursement outcomes for drugs, medical devices, and digital therapies amongst public and private payer organizations. Ms. Naz currently develops innovative contracts and provides research and management with complex projects across multiple D2 business units.
Mr. Saunders possess an extensive background and deep knowledge in market access and reimbursement. Additionally, he provides expertise in strategic sales and marketing, focusing on new market introductions of pharmaceutical, biotech, medical device and clinical lab services. Mr. Saunders has extensive training and experience in management, sales force development, contract negotiations, brand positioning, strategic planning and budgeting for profit improvement.
D2 works collaboratively with your team to properly position your product into the desired sales channels while at the same time working to ensure reimbursement success at the commercial and government payer levels. Our team provides trade/supply chain experts, pharmacists, managed care professionals, executive management and financial specialists at your disposal at a fraction of the cost of creating an internal structure.
D2 brings the experience of launching over 200 pharmaceutical, biotech and medical device products while working collaboratively with over 300 manufacturers, distributors and other industry stakeholders. This experience provides the insights needed to see clearly the opportunities, challenges and solutions that can be driven to ensure a successful commercial effort.
We believe that our combination of strategy development and tactical execution makes D2 a unique consulting partner. D2’s team has launched hundreds of products over the years and provides both the buyer (SP, PBM, Wholesaler, Retailer etc.), the Seller (manufacturer) perspective and the Reimbursement provider (Payer, PBM).
D2 is made up of experienced industry personnel from across a multitude of disciplines within the pharmaceutical, biotech and medical device arenas, including: Third Party Logistics (3PL), Wholesale, Retail, PBM, LTC, Hospital/IDN, Specialty/Infusion Pharmacy, Specialty Distribution, Mail Order, Manufacturer, and Payer including: Commercial, Government, GPO and Employer Groups.
© 2017 D2 Pharma Consulting LLC. All Rights Reserved